Home > Insider Trading > Filing (0000905148-21-000612)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1439725	Biodesix Inc	BDSX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1021413	John Patience	2970 Wilderness Place Suite 100 Boulder CO 80301		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-08-17	1,604	$7.12	1,912,474	No	4	P	Indirect	By Patience Enterprises LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Patience Enterprises LP

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	58,597	Direct
Common Stock	2,811,353	Indirect	By John Patience Living Trust dated 7/23/1993
Common Stock	30,000	Indirect	By Spouse

Footnotes

The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The reporting person is the sole trustee of John Patience Trust (July 23, 1993).
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.94 to $7.25, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
In the Form 4 filed by the Reporting Person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned in Table I was inadvertently overstated by 98 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned by the Reporting Person.
In the Form 4 filed by the Reporting Person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned in Table I was inadvertently overstated by 78 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned by the Reporting Person.